Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk ( ARCH) trial-Reference-Cited by-同舟云学术

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk ( ARCH) trial

Published:2021-08-10 Issue:11 Volume:36 Page:2139-2152
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Brown Jacques P.¹^ORCID,Engelke Klaus²³,Keaveny Tony M.⁴,Chines Arkadi⁵,Chapurlat Roland⁶^ORCID,Foldes A. Joseph⁷,Nogues Xavier⁸,Civitelli Roberto⁹^ORCID,De Villiers Tobias¹⁰,Massari Fabio¹¹,Zerbini Cristiano A.F.¹²,Wang Zhenxun⁵,Oates Mary K.⁵,Recknor Christopher¹³,Libanati Cesar¹⁴^ORCID

Affiliation:

1. Centre Hospitalier Universitaire (CHU) de Québec Research Centre, Department of Medicine, Rheumatology Division Laval University Quebec City Québec Canada

2. Bioclinica Hamburg Germany

3. Department of Medicine 3 Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany

4. Departments of Mechanical Engineering and Bioengineering University of California Berkeley Berkeley California USA

5. Amgen Inc. Thousand Oaks California USA

6. Institut National de la Santé et de la Recherche Médicale (INSERM) Unités Mixtes de Recherche (UMR) 1033 Université de Lyon, Hôpital E Herriot Lyon France

7. Osteoporosis Center Hadassah Hebrew University Medical Center Jerusalem Israel

8. Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES) Autonomous University of Barcelona Barcelona Spain

9. Musculoskeletal Research Center Washington University School of Medicine St. Louis Missouri USA

10. Department of Obstetrics and Gynaecology Stellenbosch University Stellenbosch South Africa

11. Instituto de Diagnóstico e Investigaciones Metabólicas Buenos Aires Argentina

12. Centro Paulista de Investigação Clinica São Paulo Brazil

13. United Osteoporosis Centers Gainesville Georgia USA

14. UCB Pharma Brussels Belgium

Funder

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4409

Reference41 articles.

1. Bone Mechanical Properties in Healthy and Diseased States

2. Quantifying the material and structural determinants of bone strength

3. Which fractures are most attributable to osteoporosis?

4. Vertebral Fractures: Clinical Importance and Management

5. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness of osteoporosis screening in older Swedish women (SUPERB);Bone;2024-10

2. Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis;Frontiers in Medicine;2024-08-14

3. The potential effect of romosozumab on perioperative management for instrumentation surgery;JOR SPINE;2024-08-05

4. Osteoporosis Evaluation and Management in Spine Surgery;Journal of the American Academy of Orthopaedic Surgeons;2024-07-30

5. A clinical study to evaluate the efficacy of the medical food, SBD111, versus placebo for the clinical dietary management of postmenopausal bone loss and menopause symptoms in otherwise healthy menopausal women: a randomized, double blind placebo-controlled trial.;2024-05-31